Literature DB >> 9466773

Evaluation of the RapID CB Plus system for identification of Corynebacterium species and other gram-positive rods.

M K Hudspeth1, S Hunt Gerardo, D M Citron, E J Goldstein.   

Abstract

Due to the difficulty of identifying Corynebacterium spp. with standard methods, we compared them with the RapID CB Plus system (Remel, Lenexa, Kans. [formerly Innovative Diagnostic Systems, Norcross, Ga.]), which consists of 4 carbohydrate and 14 preformed enzyme tests, for the identification of 98 clinical isolates of Corynebacterium sp., other coryneforms, Listeria monocytogenes, and 17 ATCC strains. Forty (95%) of 42 strains of Corynebacterium spp. were accurately identified to the species level by the RapID CB Plus system, and two additional strains of C. striatum were identified with one additional conventional test for lipid requirement. Twenty-seven (75%) of the 36 coryneform strains tested were identified correctly to the species level. However, three of four strains of Brevibacterium sp. and all seven of the L. monocytogenes strains were identified to the genus level only. Actinomyces strains had variable results, and the one strain of Arcanobacterium haemolyticum tested was not identified. Overall, the RapID CB Plus system compared favorably with the conventional methods, was easy to inoculate and interpret, and is promising as a new method for identification of gram-positive bacilli.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9466773      PMCID: PMC104574     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  16 in total

1.  Use of the rapid fermentation test in determining carbohydrate reactions of fastidious bacteria in clinical laboratories.

Authors:  D G Hollis; F O Sottnek; W J Brown; R E Weaver
Journal:  J Clin Microbiol       Date:  1980-10       Impact factor: 5.948

2.  Simple color tests based on an alanyl peptidase reaction which differentiate Listeria monocytogenes from other Listeria species.

Authors:  A G Clark; J McLaughlin
Journal:  J Clin Microbiol       Date:  1997-08       Impact factor: 5.948

3.  Fatal sepsis caused by Corynebacterium amycolatum in a premature infant.

Authors:  R Berner; K Pelz; C Wilhelm; A Funke; J U Leititis; M Brandis
Journal:  J Clin Microbiol       Date:  1997-04       Impact factor: 5.948

Review 4.  Clinical microbiology of coryneform bacteria.

Authors:  G Funke; A von Graevenitz; J E Clarridge; K A Bernard
Journal:  Clin Microbiol Rev       Date:  1997-01       Impact factor: 26.132

5.  Evaluation of the rapid CORYNE identification system for Corynebacterium species and other coryneforms.

Authors:  S E Gavin; R B Leonard; A M Briselden; M B Coyle
Journal:  J Clin Microbiol       Date:  1992-07       Impact factor: 5.948

6.  Antimicrobial susceptibility patterns of some recently established coryneform bacteria.

Authors:  G Funke; V Pünter; A von Graevenitz
Journal:  Antimicrob Agents Chemother       Date:  1996-12       Impact factor: 5.191

7.  Sepsis due to coryneform group A-4 in an immunocompromised host.

Authors:  G A Bizette; S A Kemmerly; J T Cole; H B Bradford; B H Peltier
Journal:  Clin Infect Dis       Date:  1995-11       Impact factor: 9.079

8.  Evidence of multiple taxa within commercially available reference strains of Corynebacterium xerosis.

Authors:  M B Coyle; R B Leonard; D J Nowowiejski; A Malekniazi; D J Finn
Journal:  J Clin Microbiol       Date:  1993-07       Impact factor: 5.948

9.  Phenotypic characteristics of 31 strains of Corynebacterium striatum isolated from clinical samples.

Authors:  L Martínez-Martínez; A I Suárez; J Winstanley; M C Ortega; K Bernard
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

10.  Evaluation of API Coryne in comparison with conventional methods for identifying coryneform bacteria.

Authors:  J Freney; M T Duperron; C Courtier; W Hansen; F Allard; J M Boeufgras; D Monget; J Fleurette
Journal:  J Clin Microbiol       Date:  1991-01       Impact factor: 5.948

View more
  9 in total

1.  Evaluation of four commercial test systems for identification of actinomyces and some closely related species.

Authors:  Anne-Marie Santala; Nanna Sarkonen; Val Hall; Petteri Carlson; Hannele Jousimies-Somer; Eija Könönen
Journal:  J Clin Microbiol       Date:  2004-01       Impact factor: 5.948

2.  Identification of clinical coryneform bacterial isolates: comparison of biochemical methods and sequence analysis of 16S rRNA and rpoB genes.

Authors:  Elisabeth E Adderson; Jan W Boudreaux; Jessica R Cummings; Stanley Pounds; Deborah A Wilson; Gary W Procop; Randall T Hayden
Journal:  J Clin Microbiol       Date:  2007-12-26       Impact factor: 5.948

3.  Evaluation of the RapID CB plus system for identification of coryneform bacteria and Listeria spp.

Authors:  G Funke; K Peters; M Aravena-Roman
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

4.  Nosocomial outbreak of Corynebacterium striatum infection in patients with chronic obstructive pulmonary disease.

Authors:  Feliu Renom; Margarita Garau; Mateu Rubí; Ferran Ramis; Antònia Galmés; Joan B Soriano
Journal:  J Clin Microbiol       Date:  2007-04-04       Impact factor: 5.948

5.  In vitro activities of the des-fluoro(6) Quinolone BMS-284756 against aerobic and anaerobic pathogens isolated from skin and soft tissue animal and human bite wound infections.

Authors:  Ellie J C Goldstein; Diane M Citron; C Vreni Merriam; Yumi A Warren; Kerin L Tyrrell; Helen Fernandez
Journal:  Antimicrob Agents Chemother       Date:  2002-03       Impact factor: 5.191

6.  Multicenter evaluation of the Vitek 2 anaerobe and Corynebacterium identification card.

Authors:  Robert P Rennie; Cheryl Brosnikoff; LeeAnn Turnbull; L Barth Reller; Stanley Mirrett; William Janda; Kathy Ristow; Ann Krilcich
Journal:  J Clin Microbiol       Date:  2008-06-18       Impact factor: 5.948

7.  Multidrug-Resistant Corynebacterium striatum Associated with Increased Use of Parenteral Antimicrobial Drugs.

Authors:  William O Hahn; Brian J Werth; Susan M Butler-Wu; Robert M Rakita
Journal:  Emerg Infect Dis       Date:  2016-11       Impact factor: 6.883

8.  Bacteraemia due to Microbacterium paraoxydans in a patient with chronic kidney disease, refractory hypertension and sarcoidosis.

Authors:  Matthew S Chorost; Nancy C Smith; Jack N Hutter; Ann C Ong; Jason A Stam; Patrick T McGann; Mary K Hinkle; Kurt E Schaecher; Edwin Kamau
Journal:  JMM Case Rep       Date:  2018-10-31

Review 9.  Clinical Characteristics of Corynebacterium Bacteremia Caused by Different Species, Japan, 2014-2020.

Authors:  Ryosuke Yamamuro; Naoto Hosokawa; Yoshihito Otsuka; Ryosuke Osawa
Journal:  Emerg Infect Dis       Date:  2021-12       Impact factor: 6.883

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.